Article and Video CATEGORIES
Did you recently receive a diagnosis of follicular lymphoma?
GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lymphoma experts listed below.
- John M. Burke, MD (Rocky Mountain Cancer Centers)
- Ian W. Flinn, MD, Ph.D. (Sarah Cannon Research Institute)
- Christopher R. Flowers, MD, MS (Emory University)
- Nathan H. Fowler, MD (The University of Texas MD Anderson Cancer Center)
- Jeff P. Sharman, MD (US Oncology Research)
To make best use of this tool, it is recommended that you have as much information about your cancer as possible before you begin. To assist you in gathering this information, click here for a PDF consultation checklist with helpful questions for your oncologist. For additional tips, please also see “How to Talk to Your Oncologist.”
If you are a health care provider, you can find CCO’s clinician-focused tool here: www.clinicaloptions.com/FLtool
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…
That's beautiful Linda. Thank you,